METHOTREXAT Mepha rheuma/derm 25 mg/0.625ml
7680655100084
CH-65510
L04AX03
07.10.6.
1 / 3
google
Details
- Product number
- 6551008
- CPT
- -
- Packaging group
- 1
- Unit
- Stück
- Composition
- methotrexatum 25 mg ut methotrexatum natricum, natrii chloridum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 0.625 ml corresp. natrium 3.54 mg.
Articles (1)
Methotrexat-Mepha rheuma/derm 25 mg/0.625 ml, Injektionslösung in einer Fertigspritze
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
25.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
3.54 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 39.75
Specialties list
Yes
Generic
Yes
SL addition date:
01/09/2018
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 65510
- Drug name
- Methotrexat-Mepha rheuma/derm, Injektionslösung in einer Fertigspritze
- Galenic form
- INLFS
- ATC Code
- L04AX03
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 20/07/2016
- Authorization expiration date
- 31/12/9999
- IT number
- 07.10.6.
- Domain
- Human medicine
Packaging details
- Description (FR)
- METHOTREXAT Mepha rheuma/derm 25 mg/0.625ml
- Description (DE)
- METHOTREXAT Mepha rheuma/derm 25 mg/0.625ml
- Market launch
- 20/07/2016
- Narcotic (BTM)
- No